Ionis Pharmaceuticals Inc
(LTS:0JDI)
$
56.98
-1.8969 (-3.22%)
Market Cap: 9.38 Bil
Enterprise Value: 9.50 Bil
PE Ratio: 0
PB Ratio: 19.16
GF Score: 71/100 Ionis Pharmaceuticals Inc at Stifel CNS Days (Virtual) Transcript
Mar 29, 2023 / 02:00PM GMT
Release Date Price:
$35.07
(+5.59%)
Paul Andrew Matteis
Stifel, Nicolaus & Company, Incorporated, Research Division - Co-Head of the Biotech Team, MD & Senior Analyst
Great. Thanks very much, everybody. It's a very topical time to have a CNS-focused discussion with Ionis, given some tau data this morning and tofersen AdCom, and maybe I can kick it off. We've got Eric and Holly here, who are very in depth on all this stuff and you both have been at Ionis for a while.
Questions & Answers
Paul Andrew Matteis
Stifel, Nicolaus & Company, Incorporated, Research Division - Co-Head of the Biotech Team, MD & Senior Analyst
As we sort of sit here today, I know you have a lot of different programs, what are the 1 to 2 things that are getting you most excited within your CNS pipeline today? Yes, maybe we can start with that.
Eric E. Swayze
Ionis Pharmaceuticals, Inc. - EVP of Research
Yes, sure. Well, thanks for having us on, Paul. We really appreciate it. We love to talk about neurology as you well know. So I guess the things that
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot